Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy
International Journal of STD & AIDS · 2023-03 · 34 (3) · 175-182
DOI: 10.1177/09564624221144489 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of STD & AIDS, online erschienen am 18.12.2022. Verfasst von Sabrina Carvalho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Ringgold: 63677Université de Montréal, Montréal, QC, Canada. Hauptthemen laut MEDLINE: HIV Infections, Pregnancy Complications, Infectious, Anti-HIV Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Background
Limited data is available on raltegravir (RAL) pharmacokinetics during pregnancy and the value of therapeutic drug monitoring (TDM) in pregnancy is unknown. This study aims to describe RAL trough plasma concentrations (C trough ) during pregnancy and review the impact of RAL TDM on outcomes.
Methods
Women from the prospective mother-infant HIV cohort of Mother and Children’s Infectious Diseases Center who received RAL during their pregnancy between 2011-2020 were included. TDM reports were reviewed and C trough values estimated when possible, using historical RAL half-lives.
Results
We included 76 pregnant women of which 47 underwent TDM. We observed a significant association between virological response and C trough ( p-value .034) with an increase of 0.1 mg/L corresponding to a 2.96 reduction in the risk of having a detectable viral load. The results indicated that in pregnant women a RAL C trough threshold of 0.04 mg/L has a higher specificity (75%) as compared to our current C trough target value of 0.02 mg/L (25%) and an acceptable sensitivity (77%). No significant differences were observed between C trough at each trimester. When comparing pregnancies with and without TDM, no statistically significant differences were observed in the virologic response during pregnancy and at delivery, or with the need for triple antiretroviral prophylaxis in newborns.
Conclusions
An association between RAL C trough and viral load was observed and achieving a RAL C trough of 0.04 mg/L or greater is a predictor of virologic response in pregnant women. The impact of TDM in pregnancy, however, could not be demonstrated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Ringgold: 63677Université de Montréal, Montréal, QC, Canada.
- Mother and Children's Infectious Diseases Center, Ringgold: 70443Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
- Pharmacy Department and Chronic Viral Illness Service, Ringgold: 54473McGill University Health Centre, Montréal, QC, Canada.
- Department of Pediatrics, Ringgold: 5622Université de Montréal, Montréal, QC, Canada.
- Department of Obstetrics and Gynecology, Ringgold: 5622Université de Montréal, Montréal, QC, Canada.
- Department of Pharmacy, Ringgold: 70443Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, Canada.
ORCID-Profile: Sabrina Carvalho, Isabelle Boucoiran
Förderung
- CIHR
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Carvalho, S., Sheehan, N. L., Valois, S., Kakkar, F., Boucher, M., Ferreira, E., & Boucoiran, I. (2023). Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy. International Journal of STD & AIDS, 34(3), 175-182. https://doi.org/10.1177/09564624221144489
Vancouver
Carvalho S, Sheehan NL, Valois S, Kakkar F, Boucher M, Ferreira E, et al. Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy. International Journal of STD & AIDS. 2023;34(3):175-182. doi:10.1177/09564624221144489
BibTeX
@article{Carvalho2023,
author = {Carvalho, Sabrina and Sheehan, Nancy L and Valois, Silvie and Kakkar, Fatima and Boucher, Marc and Ferreira, Ema and Boucoiran, Isabelle},
title = {Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy},
journal = {International Journal of STD & AIDS},
year = {2023},
volume = {34},
number = {3},
pages = {175--182},
doi = {10.1177/09564624221144489}
}
EUVIMED